Compare DTM & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DTM | RVTY |
|---|---|---|
| Founded | 2021 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 11.8B |
| IPO Year | 2021 | 1994 |
| Metric | DTM | RVTY |
|---|---|---|
| Price | $142.21 | $98.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 15 |
| Target Price | ★ $134.80 | $113.00 |
| AVG Volume (30 Days) | 812.0K | ★ 1.2M |
| Earning Date | 05-22-2026 | 04-27-2026 |
| Dividend Yield | ★ 2.47% | 0.28% |
| EPS Growth | ★ 19.44 | N/A |
| EPS | ★ 4.30 | 2.07 |
| Revenue | $1,243,000,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $9.25 | $6.34 |
| Revenue Next Year | $7.51 | $5.10 |
| P/E Ratio | ★ $33.02 | $47.49 |
| Revenue Growth | ★ 26.71 | N/A |
| 52 Week Low | $83.30 | $81.36 |
| 52 Week High | $142.85 | $120.39 |
| Indicator | DTM | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 79.25 | 45.87 |
| Support Level | $102.20 | $88.56 |
| Resistance Level | N/A | $102.44 |
| Average True Range (ATR) | 3.65 | 3.37 |
| MACD | 0.44 | -0.01 |
| Stochastic Oscillator | 95.09 | 73.01 |
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.